OTCPK:USNU

Stock Analysis Report

U.S. NeuroSurgical Holdings

Executive Summary

U.S. NeuroSurgical Holdings, Inc., through its subsidiaries, owns and operates stereotactic radiosurgery centers that utilize gamma knife technology.

Snowflake

Fundamentals

Flawless balance sheet and fair value.

Risks

  • U.S. NeuroSurgical Holdings has significant price volatility in the past 3 months.
  • U.S. NeuroSurgical Holdings is not covered by any analysts.

Share Price & News

How has U.S. NeuroSurgical Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-0.4%

USNU

0.008%

US Healthcare

-0.2%

US Market


1 Year Return

-11.9%

USNU

-9.0%

US Healthcare

1.1%

US Market

USNU underperformed the Healthcare industry which returned -9.4% over the past year.

USNU underperformed the Market in United States of America which returned 1.6% over the past year.


Share holder returns

USNUIndustryMarket
7 Day-0.4%0.008%-0.2%
30 Day-0.4%-0.8%2.5%
90 Day4.1%-1.5%1.6%
1 Year-11.9%-11.9%-7.6%-9.0%3.4%1.1%
3 Year-10.2%-10.2%29.6%24.4%45.2%35.8%
5 Year-24.9%-24.9%66.2%56.2%62.6%44.8%

Price Volatility Vs. Market

How volatile is U.S. NeuroSurgical Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is U.S. NeuroSurgical Holdings undervalued based on future cash flows and its price relative to the stock market?

>50%

Discount to future cash flow value


Intrinsic Value Based on Future Cash Flows

U.S. NeuroSurgical Holdings's share price is below the future cash flow value, and at a moderate discount (> 20%).

U.S. NeuroSurgical Holdings's share price is below the future cash flow value, and at a substantial discount (> 40%).


Price Based on Earnings

U.S. NeuroSurgical Holdings is loss making, we can't compare its value to the US Healthcare industry average.

U.S. NeuroSurgical Holdings is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for U.S. NeuroSurgical Holdings, we can't assess if its growth is good value.


Price Based on Value of Assets

U.S. NeuroSurgical Holdings is good value based on assets compared to the US Healthcare industry average.


Next Steps

Future Growth

How is U.S. NeuroSurgical Holdings expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

33.7%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Unable to determine if U.S. NeuroSurgical Holdings is high growth as no revenue estimate data is available.

U.S. NeuroSurgical Holdings's earnings are expected to grow significantly at over 20% yearly.

Unable to compare U.S. NeuroSurgical Holdings's revenue growth to the United States of America market average as no estimate data is available.

U.S. NeuroSurgical Holdings's earnings growth is expected to exceed the United States of America market average.

U.S. NeuroSurgical Holdings's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

Unable to establish if U.S. NeuroSurgical Holdings will efficiently use shareholders’ funds in the future without estimates of Return on Equity.


Next Steps

Past Performance

How has U.S. NeuroSurgical Holdings performed over the past 5 years?

-22.9%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

U.S. NeuroSurgical Holdings does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare U.S. NeuroSurgical Holdings's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare U.S. NeuroSurgical Holdings's 1-year growth to the US Healthcare industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if U.S. NeuroSurgical Holdings has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if U.S. NeuroSurgical Holdings has efficiently used its assets last year compared to the US Healthcare industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if U.S. NeuroSurgical Holdings improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is U.S. NeuroSurgical Holdings's financial position?


Financial Position Analysis

U.S. NeuroSurgical Holdings is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

U.S. NeuroSurgical Holdings's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

U.S. NeuroSurgical Holdings has no debt.

U.S. NeuroSurgical Holdings has no debt compared to 5 years ago when it was 30%.

U.S. NeuroSurgical Holdings has no debt, it does not need to be covered by operating cash flow.

U.S. NeuroSurgical Holdings has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet

Low level of unsold assets.

U.S. NeuroSurgical Holdings has no debt, it does not need to be covered by short term assets.


Next Steps

Dividend

What is U.S. NeuroSurgical Holdings's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate U.S. NeuroSurgical Holdings's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate U.S. NeuroSurgical Holdings's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as U.S. NeuroSurgical Holdings has not reported any payouts.

Unable to verify if U.S. NeuroSurgical Holdings's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as U.S. NeuroSurgical Holdings has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of U.S. NeuroSurgical Holdings's salary, the management and board of directors tenure and is there insider trading?

US$300k

CEO Compensation


CEO

Alan Gold (74yo)

0yrs

Tenure

US$300,000

Compensation

Mr. Alan Gold has been the Chairman and President of US Neurosurgical Inc. since 1996 and serves as the Chief Executive Officer. He served as Principal Financial Officer at U.S. Neurosurgical Holdings,. Mr ...


CEO Compensation Analysis

Alan's remuneration is lower than average for companies of similar size in United States of America.

Alan's compensation has been consistent with company performance over the past year, both up more than 20%.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Alan Gold (74yo)

    President

    • Tenure: 0yrs
    • Compensation: US$300.00k
  • Susan Greenwald (73yo)

    VP of Marketing Communications & Secretary

    • Tenure: 20.3yrs
  • Stan Shuman (83yo)

    Executive

    • Tenure: 0yrs
  • William Schneider

    Executive Vice President of Business Development

    • Tenure: 0yrs

Board Members

  • Alan Gold (74yo)

    President

    • Tenure: 0yrs
    • Compensation: US$300.00k
  • Bill Leimkuhler (68yo)

    Lead Director

    • Tenure: 0yrs
  • Charles Merriman (85yo)

    Director

    • Tenure: 20.3yrs

Company Information

U.S. NeuroSurgical Holdings, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: U.S. NeuroSurgical Holdings, Inc.
  • Ticker: USNU
  • Exchange: OTCPK
  • Founded: 1993
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: US$1.784m
  • Shares outstanding: 7.79m
  • Website: https://www.usneuro.com

Number of Employees


Location

  • U.S. NeuroSurgical Holdings, Inc.
  • 2400 Research Boulevard
  • Suite 325
  • Rockville
  • Maryland
  • 20850
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
USNUOTCPK (Pink Sheets LLC)YesCommon StockUSUSDOct 1999

Biography

U.S. NeuroSurgical Holdings, Inc., through its subsidiaries, owns and operates stereotactic radiosurgery centers that utilize gamma knife technology. The gamma knife is a stereotactic radiosurgical device  ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/20 00:21
End of Day Share Price2019/09/17 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.